African drugmaker Aspen bets on GLP-1 drugs to boost profit

African drugmaker Aspen bets on GLP-1 drugs to boost profit

Source: 
Reuters
snippet: 
  • Aspen's FY core profit up 1%
  • Secures licence to commercialise GLP-1 drugs
  • Eli Lilly's Mounjaro could launch by year-end in S.Africa